Continuous Glucose Sensor Signal Processing for Dilution Artifact Compensation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Continuous glucose monitors (CGMs) face inaccuracies due to dilution artifacts caused by the delivery of insulin or other compositions near the sensor, leading to underestimation of true glucose levels, which can result in inappropriate insulin adjustments by patients.

Innovation Solution

A method involving a sensor that measures analyte concentrations in subcutaneous fluid, combines these measurements with forecasting models, such as machine learning or glucoregulatory models, and signal processing to estimate true analyte concentrations, mitigating dilution artifacts by predicting future glucose values and using Kalman filters for optimal estimation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If a composition is delivered near the sensor to enable integrated monitoring and therapy, then device integration and convenience are improved, but measurement precision deteriorates due to dilution artifacts

Engineering Contradiction:
Improvedevice integrationVSAvoidglucose measurement accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The system identifies composition delivery events in advance using pump notifications or flow detection, then preemptively switches to forecasted glucose values before the dilution artifact occurs. This preliminary action prevents the measurement error from affecting the displayed glucose reading.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A forecast model acts as an intermediary between the sensor and the user interface. Instead of displaying raw sensor measurements directly, the system uses the forecast model to generate compensated glucose values that account for upcoming dilution artifacts, providing accurate readings without the interference.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Device complexity

If raw sensor measurements are used directly, then device complexity is reduced, but measurement precision deteriorates due to dilution artifacts

Engineering Contradiction:
Improvesignal processing complexityVSAvoidglucose measurement accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The system continuously monitors sensor readings and compares them with forecast model predictions. When a discrepancy indicating dilution artifact is detected, the system provides feedback by switching to the forecasted values, creating a closed-loop system that automatically corrects measurement errors.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system changes the parameter being displayed from raw sensor voltage/current to processed forecasted glucose concentrations. This parameter transformation eliminates the dilution artifact effect while maintaining the essential glucose monitoring function.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If the sensor is placed close to the delivery site for integrated device design, then device versatility is improved, but measurement precision deteriorates due to interstitial fluid dilution

Engineering Contradiction:
Improveintegrated sensor-delivery designVSAvoidanalyte concentration accuracy
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The harmful dilution effect is extracted and identified as a separate detectable event through flow sensors or pump notifications. By taking out the dilution artifact as a distinct phenomenon, the system can compensate for it using forecast models rather than being overwhelmed by the direct measurement error.

Inventive Principle:
Principle #2Taking out (Extraction)

Data Source

PatentUS20220386905A1Signal processing algorithm for improving accuracy of a continuous glucose sensor and a combined continuous glucose sensor and insulin delivery cannula
Publication Date: 2022.12.08 PACIFIC DIABETES TECHNOLOGIES INC
  • US20220386905A1 patent drawing
  • US20220386905A1 patent drawing
  • US20220386905A1 patent drawing

AI summary

The present disclosure provides methods of measuring of an analyte in a subject to remove a measurement artifact by using a forecasting model to determine the true analyst concentration in a subject. Also herein, the present disclosure provides parameters and models to estimate the true analyte concentration in a subject.